L F Gulli, K C Palmer, Y Q Chen, K B Reddy
Index: Cell Growth Differ. 7(2) , 173-8, (1996)
Full Text: HTML
A431 cells overexpress epidermal growth factor receptors (EGF-Rs) and are inhibited by EGF. We show that treatment of A431 cells with 10 nM EGF induced a 15-fold increase in EGF-R autophosphorylation, leading to inhibition of cell proliferation and morphological features of apoptosis. However, at a lower concentration of EGF (0.01 nM), there is a 2-fold increase in EGF-R autophosphorylation and increased cell proliferation when compared to untreated cells. EGF treatment is associated with increased expression of c-myc and decreased expression of mutant p53 and p21/WAF protein. When A431 cells were simultaneously treated with 10 nM EGF and EGF-R antibody, there was a significant reduction in EGF-R autophosphorylation that was associated with increased cell proliferation. Based on these results, we postulate that overexpression of EGF-R could allow for selective growth advantage for tumor cells in the presence of normal or decreased ligand availability. However, excessive ligand binding would result in deregulated growth signaling, leading to growth inhibition and programmed cell death.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
RG-13022
CAS:136831-48-6 |
C16H14N2O2 |
The antiproliferative effects of tyrosine kinase inhibitors ...
1991-08-15 [Cancer Res. 51 , 4430, (1991)] |
Intrapituitary regulatory system of mammotrophs in the mouse...
2002-04-01 [Arch. Physiol. Biochem. 110(1-2) , 34-41, (2002)] |
Inhibition of breast cancer cell growth in vitro by a tyrosi...
1992-07-01 [Cancer Res. 52(13) , 3636-41, (1992)] |
Activation of the epidermal growth factor receptor by skin t...
1995-11-01 [Cell Growth Differ. 6(11) , 1447-55, (1995)] |
Tyrosine kinase inhibitor as a novel signal transduction and...
1996-03-01 [Mol. Cell. Endocrinol. 117(1) , 53-8, (1996)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved